Provided by Tiger Fintech (Singapore) Pte. Ltd.

CHINARES PHARMA

5.230
-0.050-0.95%
Volume:8.96M
Turnover:47.16M
Market Cap:32.86B
PE:9.03
High:5.330
Open:5.330
Low:5.230
Close:5.280
Loading ...

BRIEF-China Resources Pharmaceutical Announces Formation Of Fund

Reuters
·
17 Jul

China Resources Pharmaceutical Group Ltd. Announces Joint Venture with China Resources Pharmaceutical (Chengdu) Enterprise Management Partnership

Reuters
·
17 Jul

China Resources Pharmaceutical Group Ltd. Appoints Wang Yuhang as Non-Executive Director

Reuters
·
18 Jun

China Resources Pharmaceutical Unit Sells 3 Billion Yuan Bonds

MT Newswires Live
·
17 Jun

China Resources Pharmaceutical Group Ltd. Held Annual General Meeting

Reuters
·
23 May

CR Sanjiu, Subsidiary of China Resources Pharmaceutical, Expands Pharmaceutical Product Line

Reuters
·
14 May

Jiang Zhong Pharmaceutical's Q1 Profit Increases

MT Newswires Live
·
28 Apr

BRIEF-China Resources Pharmaceutical Says QTRLY Net Profit Rmb425.0 Million For Dong-E-E-Jiao

Reuters
·
28 Apr

China Resources Pharma Unit Issues 400 Million Yuan of Bonds

MT Newswires Live
·
25 Apr

BRIEF-China Resources Pharmaceutical Posts Qtrly Results For China Resources Boya Bio-Pharmaceutical

Reuters
·
25 Apr

Stock Track | China Resources Pharmaceutical Plummets 5.13% Following Disappointing 2024 Profit Results

Stock Track
·
26 Mar

China Resources Pharmaceutical's 2024 Profit Slides; Shares Fall 4%

MT Newswires Live
·
26 Mar

BRIEF-China Resources Pharmaceutical Says FY Net Profit Attributable For Jiangzhong Pharmaceutical Was RMB788.2 Million

Reuters
·
19 Mar

BRIEF-China Resources Pharmaceutical Posts FY Results For CR Double-Crane Pharmaceutical

Reuters
·
19 Mar

China Resources Pharmaceutical Posts FY Net Profit Attributable Of CR Boya Bio-Pharmaceutical Of RMB397 Million

Reuters
·
18 Mar

China Resources Pharmaceutical Posts FY Revenue RMB5.92 Bln For Dong-E-E-Jiao

Reuters
·
18 Mar

CR Sanjiu Logs 18% Boost in 2024 Profit

MT Newswires Live
·
13 Mar

KPC Pharmaceuticals' 2024 Profit Rises 20%

MT Newswires Live
·
12 Mar

China Resources Pharmaceutical Group Limited's (HKG:3320) Shares May Have Run Too Fast Too Soon

Simply Wall St.
·
11 Feb

KPC Pharmaceuticals Records 46% Higher Net Attributable Profit in 2024

MT Newswires Live
·
10 Feb